Melanie Alpaugh, Juan Lantero Rodrı́guez, Andréa Lessa Benedet, Uriel Manseau-Pérez, Molly E. Boutin, Massimo Maiuri, Hélèna L. Denis, Maria Masnata, Shaline V. Fazal, Sylvain Chouinard, Pedro Rosa-Neto, Roger A. Barker, Kaj Blennow, Henrik Zetterberg, Richard Labib and Francesca Cicchetti
Article (2025)
An external link is available for this itemDepartment: | Department of Mathematics and Industrial Engineering |
---|---|
PolyPublie URL: | https://publications.polymtl.ca/63295/ |
Journal Title: | Journal of Neurology (vol. 272, no. 3) |
Publisher: | Springer Science+Business Media |
DOI: | 10.1007/s00415-025-12966-9 |
Official URL: | https://doi.org/10.1007/s00415-025-12966-9 |
Date Deposited: | 10 Mar 2025 13:50 |
Last Modified: | 08 Apr 2025 07:32 |
Cite in APA 7: | Alpaugh, M., Rodrı́guez, J. L., Benedet, A. L., Manseau-Pérez, U., Boutin, M. E., Maiuri, M., Denis, H. L., Masnata, M., Fazal, S. V., Chouinard, S., Rosa-Neto, P., Barker, R. A., Blennow, K., Zetterberg, H., Labib, R., & Cicchetti, F. (2025). Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity. Journal of Neurology, 272(3), 11 pages. https://doi.org/10.1007/s00415-025-12966-9 |
---|---|
Statistics
Dimensions